J. U. McDonald

发表

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

P. Taylor, F. Finkelman, D. Zillikens, 2012, Nature Medicine.

The Induction of Inflammation by Dectin-1 In Vivo Is Dependent on Myeloid Cell Programming and the Progression of Phagocytosis1

P. Taylor, David L. Williams, Gordon D. Brown, 2008, The Journal of Immunology.

Phagocytosis Programming and the Progression of In Vivo Is Dependent on Myeloid Cell The Induction of Inflammation by Dectin-1

P. Taylor, David L. Williams, Gordon D. Brown, 2008 .

Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model

S. Clare, G. Dougan, P. Kellam, 2013, PloS one.

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies

Ranawaka A.P.M Perera, A. McDermott, A. García-Sastre, 2020, Vaccines.

Erratum: Airway T cells protect against RSV infection in the absence of antibody

J. Tregoning, J. U. McDonald, L. Lambert, 2017, Mucosal Immunology.

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease

J. Tregoning, B. Bogen, J. U. McDonald, 2016, Front. Immunol..

responses, enabling Faster resolution of influenza Disease

J. Tregoning, B. Bogen, J. U. McDonald, 2016 .

Inflammatory responses to influenza vaccination at the extremes of age

J. Tregoning, J. U. McDonald, Helen T Groves, 2017, Immunology.

In vivo functional analysis and genetic modification of in vitro‐derived mouse neutrophils

P. Taylor, Simon A. Jones, M. Hallett, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection

Belinda Wang, P. Collins, C. Johansson, 2013, Proceedings of the National Academy of Sciences.

Use of the microparticle Nano-SiO2 as an adjuvant to boost vaccine immune responses in neonatal mice against influenza

J. Tregoning, J. U. McDonald, L. Lambert, 2016 .

Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines

R. Shattock, J. Tregoning, A. Walters, 2014, Gene Therapy.

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

J. Tregoning, J. U. McDonald, A. Bukreyev, 2015, Journal of Virology.

Conditional immortalisation of myeloid-precursors to model innate immunity

J. U. McDonald, Jacqueline U. McDonald, 2013 .

Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy

P. Kellam, J. McCauley, W. Barclay, 2018, Front. Immunol..

Development of a custom pentaplex sandwich immunoassay using Protein-G coupled beads for the Luminex® xMAP® platform.

J. Ekeruche-Makinde, J. Tregoning, J. U. McDonald, 2016, Journal of immunological methods.

Phagocytosis Is the Main CR3-Mediated Function Affected by the Lupus-Associated Variant of CD11b in Human Myeloid Cells

P. Taylor, T. Malik, G. Ling, 2013, PloS one.

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

O. Engelhardt, P. Rigsby, J. U. McDonald, 2018, Vaccine.

Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice

J. Tregoning, J. U. McDonald, L. Lambert, 2016, Journal of Virology.

Differential Dependencies of Monocytes and Neutrophils on Dectin-1, Dectin-2 and Complement for the Recognition of Fungal Particles in Inflammation

P. Taylor, Simon A. Jones, Gordon D. Brown, 2012, PloS one.

A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease

S. Clare, M. Kaforou, V. Wright, 2016, mSystems.

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.

O. Engelhardt, P. Rigsby, J. U. McDonald, 2019, Vaccine.

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

W. Ramage, C. Ball, O. Engelhardt, 2022, Vaccines.